Alterations of fecal short-chain fatty acids solely in the course of multiple sclerosis: rethinking the gut–brain axis in the early stages of MS
Background: The role of gut microbiota in multiple sclerosis (MS) has become increasingly important, intestinal dysbiosis with reduced production of short-chain fatty acids (SCFA) being the prevailing paradigm. However, the direction of causality, that is, whether intestinal changes are cause or con...
Tallennettuna:
| Päätekijät: | , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
SAGE Publishing
2025-12-01
|
| Sarja: | Therapeutic Advances in Neurological Disorders |
| Linkit: | https://doi.org/10.1177/17562864251396028 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|